Recent Updates
Recently added Catalysts
RIGL Positive Sentiment Score: 70/100

Rigel to Present at the Jefferies London Healthcare Conference

Tuesday, November 12, 2024 1 min read
Key Takeaway: Rigel Pharmaceuticals, Inc. announced that its CFO, Dean Schorno, will present an overview at the Jefferies London Healthcare Conference on November 19, 2024. This event showcases Rigel's commitment to engaging with stakeholders and providing insights into its business strategy and pipeline. Investors can access the live webcast through the company's website, emphasizing transparency in communications. Rigel continues to focus on developing novel therapies for hematologic disorders and cancer.

Market Sentiment Analysis

POSITIVE FACTORS

  • Rigel's presentation at a significant healthcare conference indicates confidence in their business strategy.
  • The company's focus on hematologic disorders and cancer aligns with urgent medical needs.
  • Access to the live webcast demonstrates transparency and investor engagement.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Dean Schorno, the company's chief financial officer, will present a company overview at the Jefferies London Healthcare Conference on Tuesday, November 19, at 9:30 am GMT (4:30 am EST).
To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Contact for Investors & Media:
Rigel Pharmaceuticals, Inc.
SOURCE Rigel Pharmaceuticals, Inc.

21 %

more press release views with

Frequently Asked Questions

When will Rigel Pharmaceuticals present at the Jefferies Conference?

Rigel Pharmaceuticals will present on November 19 at 9:30 am GMT.

Who is presenting for Rigel Pharmaceuticals at the conference?

Dean Schorno, the CFO of Rigel Pharmaceuticals, will present.

How can I access Rigel's conference presentation?

Access the live webcast or recording via the Investor Relations section on Rigel's website.

What does Rigel Pharmaceuticals focus on?

Rigel focuses on hematologic disorders and cancer therapies.

Where is Rigel Pharmaceuticals located?

Rigel Pharmaceuticals is based in South San Francisco, California.

Tags: RIGL Viatris Investor Conferences Healthcare Jefferies Conference biotechnology haematologic disorders cancer therapies
Last updated: Nov 12, 2024